HIV gene amplification meeting
This article was originally published in The Gray Sheet
Executive SummaryFDA will hold a public meeting Sept. 26-28 in Silver Spring, Maryland to consider "the feasibility and utility of gene amplification techniques to enhance viral detection in the seronegative 'window' phase" of HIV infection, according to an Aug. 1 Federal Register notice. Topics to be discussed include the current status of techniques "for the detection of genetic sequences by amplification" and their applicability to donor screening, as well as "procedural and economic aspects" of utilizing these techniques. For more information, contact Nicholas Reuter at 301/443-1382
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.